A Part of the University of Maryland Medical Center

• Overview
• Questions and Answers About Milk Thistle
• Current Clinical Trials
• General CAM Information
• Evaluation of CAM Approaches
• Questions to Ask Your Health Care Provider About CAM
• To Learn More About CAM

• Information for Patients

• Patient Care
• Being Admitted
• UMGCC Directory
• Schedule an Appointment
• Ask the Expert
• Patient Education
• Dictionary of Cancer Terms
• Cancer Topics
• Parking, Lodging and Restaurants
• 2012 Cancer Patient Event: A Day of Honor
• Podcasts
• Audio/Video Library
• 
    Related Resources
• Center for Image Renewal
• Clinical Trials
• Contact Us
• Patient Web Pages

Evaluation of CAM Approaches

It is important that the same rigorous scientific evaluation used to assess conventional approaches be used to evaluate CAM therapies. The National Cancer Institute (NCI) and the National Center for Complementary and Alternative Medicine (NCCAM) are sponsoring a number of clinical trials (research studies) at medical centers to evaluate CAM therapies for cancer.

Conventional approaches to cancer treatment have generally been studied for safety and effectiveness through a rigorous scientific process that includes clinical trials with large numbers of patients. Less is known about the safety and effectiveness of complementary and alternative methods. Few CAM therapies have undergone rigorous evaluation. A small number of CAM therapies originally considered to be purely alternative approaches are finding a place in cancer treatment—not as cures, but as complementary therapies that may help patients feel better and recover faster. One example is acupuncture. According to a panel of experts at a National Institutes of Health (NIH) Consensus Conference in November 1997, acupuncture has been found to be effective in the management of chemotherapy-associated nausea and vomiting and in controlling pain associated with surgery. In contrast, some approaches, such as the use of laetrile, have been studied and found ineffective or potentially harmful.

The NCI Best Case Series Program, which was started in 1991, is one way CAM approaches that are being used in practice are being investigated. The program is overseen by the NCI’s Office of Cancer Complementary and Alternative Medicine (OCCAM). Health care professionals who offer alternative cancer therapies submit their patients’ medical records and related materials to OCCAM. OCCAM conducts a critical review of the materials and develops follow-up research strategies for approaches deemed to warrant NCI-initiated research.